Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...

The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...

Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...

Scientists have pinpointed a brain circuit that, when activated, reduces anxiety without impairing memory. Using ...

Researchers uncover key mechanisms in gene regulation that may lead to better design of RNA-based medicines.

A patent has been granted in the US covering the use of Neurizon’s lead drug candidate NUZ-001 in neurodegenerative diseases ...

Smart watches, rings, and a growing array of patches are adding more functionality and being used across a growing set of ...